Skip to main content
. 2016 May 4;9:2667–2674. doi: 10.2147/OTT.S98408

Figure 2.

Figure 2

Baseline expression of serum miR-199a/b-3p in patients with HCC before first TACE (t1) was significantly lower compared with healthy controls (0.68±0.81 vs 2.50±2.16, P<0.001; N=132).

Abbreviations: HCC, hepatocellular carcinoma; miR-199a/b-3p, microRNA-199a/b-3p; TACE, transarterial chemoembolization.